Erectile dysfunction.
作者信息
Katz Alan, Katz Anne
机构信息
Department of Family Medicine, University of Manitoba, Winnipeg, Manitoba.
出版信息
CMAJ. 2010 Mar 9;182(4):381-2. doi: 10.1503/cmaj.090422. Epub 2010 Feb 8.
Abstract
摘要
相似文献
1
Erectile dysfunction.勃起功能障碍
CMAJ. 2010 Mar 9;182(4):381-2. doi: 10.1503/cmaj.090422. Epub 2010 Feb 8.
2
Failure of PDE5 inhibitor use: a case of nonresponder? (CME).磷酸二酯酶5抑制剂使用失败：一例无反应者？（继续医学教育）
J Sex Med. 2010 Apr;7(4 Pt 1):1321-3. doi: 10.1111/j.1743-6109.2010.01772.x.
3
How new drugs help treat erectile dysfunction.新药如何帮助治疗勃起功能障碍。
Nursing. 2006 Jan;36(1):18-9. doi: 10.1097/00152193-200601000-00013.
4
The ENDOTRIAL study: a spontaneous, open-label, randomized, multicenter, crossover study on the efficacy of sildenafil, tadalafil, and vardenafil in the treatment of erectile dysfunction.ENDOTRIAL 研究：西地那非、他达拉非和伐地那非治疗勃起功能障碍的疗效的自发、开放标签、随机、多中心、交叉研究。
J Sex Med. 2009 Sep;6(9):2547-60. doi: 10.1111/j.1743-6109.2009.01375.x. Epub 2009 Jun 29.
5
6
Patient education series. Erectile dysfunction.患者教育系列。勃起功能障碍。
Nursing. 2005 Feb;35(2):64. doi: 10.1097/00152193-200502000-00043.
7
New phosphodiesterase type 5 inhibitors in the management of erectile dysfunction.新型5型磷酸二酯酶抑制剂在勃起功能障碍治疗中的应用
J R Soc Promot Health. 2003 Jun;123(2):79-80. doi: 10.1177/146642400312300209.
8
Pharmacologic update: treatment of erectile dysfunction in the elderly with phosphodiesterase type 5 inhibitors: cardiovascular implications.药物学最新进展：老年勃起功能障碍患者使用5型磷酸二酯酶抑制剂治疗的心血管影响
Am J Geriatr Cardiol. 2004 Nov-Dec;13(6):332-5. doi: 10.1111/j.1076-7460.2004.02725.x.
9
There have been inadequate warnings that erectile dysfunction drugs can cause blindness.一直以来都存在警示不足的情况，即勃起功能障碍药物可能会导致失明。
MedGenMed. 2005 Dec 5;7(4):61.
10
Medication utilization behavior in patients receiving phosphodiesterase type 5 inhibitors for erectile dysfunction.接受5型磷酸二酯酶抑制剂治疗勃起功能障碍患者的用药行为。
J Sex Med. 2005 Nov;2(6):848-55. doi: 10.1111/j.1743-6109.2005.00149.x.
引用本文的文献
1
2
Taking the stress out of treating erectile dysfunction.缓解治疗勃起功能障碍的压力。
Can Fam Physician. 2010 Sep;56(9):898-903.
本文引用的文献
1
Hormonal testing and pharmacologic treatment of erectile dysfunction: a clinical practice guideline from the American College of Physicians.勃起功能障碍的激素检测与药物治疗：美国医师学会临床实践指南
Ann Intern Med. 2009 Nov 3;151(9):639-49. doi: 10.7326/0003-4819-151-9-200911030-00151.
2
Testosterone replacement therapy and prostate cancer: a word of caution.睾酮替代疗法与前列腺癌：一则警示
Curr Urol Rep. 2007 May;8(3):185-9. doi: 10.1007/s11934-007-0004-x.
3
Visual loss with erectile dysfunction medications.勃起功能障碍药物导致的视力丧失。
CMAJ. 2006 Aug 15;175(4):355. doi: 10.1503/cmaj.060935. Epub 2006 Jul 26.
4
Erectile dysfunction and subsequent cardiovascular disease.勃起功能障碍与随后的心血管疾病。
JAMA. 2005 Dec 21;294(23):2996-3002. doi: 10.1001/jama.294.23.2996.
5
The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine.关于性功能障碍与心脏风险的第二个普林斯顿共识：性医学新指南
J Sex Med. 2006 Jan;3(1):28-36; discussion 36. doi: 10.1111/j.1743-6109.2005.00196.x.
6
Sex and the heart.性别与心脏
Int J Impot Res. 2005 Dec;17 Suppl 1:S4-6. doi: 10.1038/sj.ijir.3901422.
7
Phosphodiesterase type 5 inhibitors for erectile dysfunction.用于治疗勃起功能障碍的5型磷酸二酯酶抑制剂。
BJU Int. 2005 Aug;96(3):257-80. doi: 10.1111/j.1464-410X.2005.05614.x.
Zotero 插件